SEC Company Response from RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772) (RAPT) — Feb 4, 2020
RAPT Therapeutics, Inc. (RAPT) (CIK 0001673772)
Date: Feb. 4, 2020 · CIK: 0001673772 · Accession: 0001193125-20-024380
AI Filing Summary & Sentiment
File numbers found in text: 333-236256
Letter
Company Acceleration Request
RAPT THERAPEUTICS, INC.
561 Eccles Avenue
South San Francisco, California 94080
February 4, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Paul Fischer
Re: RAPT Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-236256)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, RAPT Therapeutics, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:15 p.m. Eastern time, on February 6, 2020, or as soon thereafter as possible, or at such other time as the Registrant may request by telephone to the Staff. The Registrant hereby authorizes each of Michael Tenta, Sale Kwon and Ryan James of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Michael Tenta of Cooley LLP at (650) 843-5636 or, in his absence, Ryan James of Cooley LLP at (650) 843-5846.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
[SIGNATURE PAGE FOLLOWS]
Very truly yours,
RAPT THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
Company Acceleration Request
RAPT THERAPEUTICS, INC.
561 Eccles Avenue
South San
Francisco, California 94080
February 4, 2020
VIA EDGAR
U.S. Securities and Exchange
Commission
Division of Corporation Finance
100 F Street,
N.E.
Washington, D.C. 20549
Attention:
Mr. Paul Fischer
Re:
RAPT Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-236256)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules
and Regulations under the Securities Act of 1933, as amended, RAPT Therapeutics, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date
of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:15 p.m. Eastern time, on February 6,
2020, or as soon thereafter as possible, or at such other time as the Registrant may request by telephone to the Staff. The Registrant hereby authorizes each of Michael Tenta, Sale Kwon and Ryan James of Cooley LLP, counsel to the Registrant, to
make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Michael Tenta of
Cooley LLP at (650) 843-5636 or, in his absence, Ryan James of Cooley LLP at (650) 843-5846.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Registrant’s request for
acceleration of the effectiveness of the Registration Statement.
[SIGNATURE PAGE FOLLOWS]
Very truly yours,
RAPT THERAPEUTICS, INC.
By:
/s/ Rodney Young
Name: Rodney Young
Title: Chief Financial Officer and Secretary
[SIGNATURE PAGE TO ACCELERATION
REQUEST LETTER]